COVID-19相关急性呼吸窘迫综合征的病理生理学:一项多中心前瞻性观察研究
该多中心前瞻性观察研究纳入意大利7家医院2020年3月9日至22日连续收治的301例实验室确诊COVID-19且符合柏林标准的有创机械通气ARDS患者,在入ICU 24小时内测量静态呼吸系统顺应性、氧合指数、通气比及D-二聚体,并与既往非COVID-19 ARDS队列比较。COVID-19相关ARDS中位静态顺应性为41 mL/cm H2O,较非COVID-19 ARDS队列的32 mL/cm H2O高28%(p<0.0001),但总肺重量无差异。D-二聚体高于中位数者通气比高于D-二聚体低于或等于中位数者(1.90 vs 1.66,p=0.0001)。静态顺应性低于或等于中位数且D-二聚体高于中位数的亚组28天死亡率显著升高(56%)。
要点
- COVID-19相关ARDS中位静态顺应性41 mL/cm H2O,较非COVID-19 ARDS队列的32 mL/cm H2O高28%(p<0.0001),但总肺重量无差异。
- 仅6%(17/297)的COVID-19相关ARDS患者顺应性超过经典ARDS队列的第95百分位,多数患者顺应性仍处于低水平。
- D-二聚体高于中位数者通气比高于D-二聚体低于或等于中位数者(1.90 vs 1.66,p=0.0001),提示死腔增加。
- 静态顺应性低于或等于中位数且D-二聚体高于中位数的亚组28天死亡率56%(40/71),显著高于其他三个亚组(27%、22%、35%,均p=0.0001)。
- 23例(8%)行CT肺动脉造影的患者中,D-二聚体高于中位数的16例中有15例(94%)见双肺低灌注区,符合血栓栓塞性疾病。
适用人群与场景
- 意大利7家医院2020年3月9日至22日连续收治的实验室确诊COVID-19、符合柏林标准ARDS、接受有创机械通气并入住ICU的成人患者,共301例。
- 所有患者均镇静、肌松并以容量控制模式通气,使用标准ICU呼吸机。
- 对照数据来自既往非COVID-19 ARDS研究的数据集。
诊断标准与关键阈值
- ARDS诊断采用柏林标准。
- 静态呼吸系统顺应性、氧合指数(PaO2/FiO2)、通气比及D-二聚体均在入ICU 24小时内测量。
- CT肺动脉造影在临床有指征时进行。
红旗征与不能漏的情况
- 静态顺应性低于或等于中位数且D-二聚体高于中位数的COVID-19相关ARDS患者28天死亡率达56%(40/71),显著高于其他亚组,需重点监护。
- D-二聚体高于中位数者通气比更高(1.90 vs 1.66,p=0.0001),提示死腔增加,需关注通气效率。
- CT肺动脉造影显示D-二聚体高于中位数者中94%(15/16)存在双肺低灌注区,符合血栓栓塞性疾病。
研究设计与关键结果
- 研究类型为多中心前瞻性观察研究,纳入意大利7家医院301例COVID-19相关ARDS患者,对照为非COVID-19 ARDS历史数据集。
- COVID-19相关ARDS中位静态顺应性41 mL/cm H2O(33-52),非COVID-19 ARDS队列为32 mL/cm H2O(25-43),前者高28%(p<0.0001)。
- COVID-19相关ARDS中17/297(6%)患者顺应性超过经典ARDS队列第95百分位;两组总肺重量无差异。
- 23例(8%)行CT肺动脉造影,D-二聚体高于中位数的16例中15例(94%)见双肺低灌注区。
- D-二聚体低于或等于中位数者通气比1.66(1.32-1.95),高于中位数者1.90(1.50-2.33),p=0.0001。
- 28天死亡率:D-二聚体高且顺应性低组56%(40/71),D-二聚体低且顺应性高组27%(18/67),D-二聚体低且顺应性低组22%(13/60),D-二聚体高且顺应性高组35%(22/63),均p=0.0001。
证据类型、等级与局限
- 证据类型:多中心前瞻性观察研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对COVID-19相关ARDS患者,入ICU 24小时内应关注静态呼吸系统顺应性与D-二聚体水平,二者联合可识别28天死亡率高达56%的高危亚组。
- COVID-19相关ARDS患者总体顺应性较非COVID-19 ARDS高28%,但仅6%超过经典ARDS第95百分位,多数患者仍表现为低顺应性,作者认为其损伤形式在许多方面与非COVID-19 ARDS相似。
- D-二聚体升高提示可能存在肺血栓栓塞性疾病,原文中D-二聚体高于中位数者CT肺动脉造影见双肺低灌注区。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Patients with COVID-19 can develop acute respiratory distress syndrome (ARDS), which is associated with high mortality. The aim of this study was to examine the functional and morphological features of COVID-19-associated ARDS and to compare these with the characteristics of ARDS unrelated to COVID-19.
METHODS: This prospective observational study was done at seven hospitals in Italy. We enrolled consecutive, mechanically ventilated patients with laboratory-confirmed COVID-19 and who met Berlin criteria for ARDS, who were admitted to the intensive care unit (ICU) between March 9 and March 22, 2020. All patients were sedated, paralysed, and ventilated in volume-control mode with standard ICU ventilators. Static respiratory system compliance, the ratio of partial pressure of arterial oxygen to fractional concentration of oxygen in inspired air, ventilatory ratio (a surrogate of dead space), and D-dimer concentrations were measured within 24 h of ICU admission. Lung CT scans and CT angiograms were done when clinically indicated. A dataset for ARDS unrelated to COVID-19 was created from previous ARDS studies. Survival to day 28 was assessed.
FINDINGS: Between March 9 and March 22, 2020, 301 patients with COVID-19 met the Berlin criteria for ARDS at participating hospitals. Median static compliance was 41 mL/cm H2O (33-52), which was 28% higher than in the cohort of patients with ARDS unrelated to COVID-19 (32 mL/cm H2O [25-43]; p<0·0001). 17 (6%) of 297 patients with COVID-19-associated ARDS had compliances greater than the 95th percentile of the classical ARDS cohort. Total lung weight did not differ between the two cohorts. CT pulmonary angiograms (obtained in 23 [8%] patients with COVID-19-related ARDS) showed that 15 (94%) of 16 patients with D-dimer concentrations greater than the median had bilateral areas of hypoperfusion, consistent with thromboembolic disease. Patients with D-dimer concentrations equal to or less than the median had ventilatory ratios lower than those of patients with D-dimer concentrations greater than the median (1·66 [1·32-1·95] vs 1·90 [1·50-2·33]; p=0·0001). Patients with static compliance equal to or less than the median and D-dimer concentrations greater than the median had markedly increased 28-day mortality compared with other patient subgroups (40 [56%] of 71 with high D-dimers and low compliance vs 18 [27%] of 67 with low D-dimers and high compliance, 13 [22%] of 60 with low D-dimers and low compliance, and 22 [35%] of 63 with high D-dimers and high compliance, all p=0·0001).
INTERPRETATION: Patients with COVID-19-associated ARDS have a form of injury that, in many aspects, is similar to that of those with ARDS unrelated to COVID-19. Notably, patients with COVID-19-related ARDS who have a reduction in respiratory system compliance together with increased D-dimer concentrations have high mortality rates.
参考来源
- Grasselli G, Tonetti T, Protti A, et al. Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study. Lancet Respir Med. 2020. PMID: 32861276. doi:10.1016/S2213-2600(20)30370-2
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。